Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_245258033.1 RVAN_RS04590 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::A6WUV8 (450 letters) >NCBI__GCF_000166055.1:WP_245258033.1 Length = 448 Score = 464 bits (1194), Expect = e-135 Identities = 249/435 (57%), Positives = 312/435 (71%), Gaps = 4/435 (0%) Query: 12 ARRSEALTGEIRIPGDKSISHRSFMFGGLASGETRITGLLEGEDVINTGRAMQAMGAKIR 71 +R+S L G + +PGDKSISHR+ + G LA G TRITGLLE ED++ T RA++A+GA + Sbjct: 2 SRKSGRLQGAVVVPGDKSISHRALILGALAEGRTRITGLLEAEDILCTARALEALGAGVE 61 Query: 72 KDGD-AWIINGVGNGCLLQPEAALDFGNAGTGARLTMGLVGTYDMRTSFIGDASLSKRPM 130 +D D AW + G G G L P LDFGN+GTGARL MG+V + + F GDASL KRPM Sbjct: 62 RDADGAWTVTGRGLGGLAAPAGDLDFGNSGTGARLMMGVVAGHPLAARFTGDASLQKRPM 121 Query: 131 GRVLNPLREMGVQVEAAEGDRMPLTLIGPKTANPITYRVPMASAQVKSAVLLAGLNTPGV 190 GRVL PL+ MG+ +E + +PLTL+G PI+YR+P+ SAQVKSAVLLAGL G Sbjct: 122 GRVLAPLQSMGLAIEEEGRNTLPLTLVGTGDLVPISYRLPVPSAQVKSAVLLAGLFASGE 181 Query: 191 TTVIEPVMTRDHTEKMLQGFGADLSVETDKDGVRHIRITGQGKLIGQTIDVPGDPSSTAF 250 T+VIE +RDHTEKML+ FGA++SVE + G+R I + G+ L GQ + VPGDPSS AF Sbjct: 182 TSVIESEKSRDHTEKMLRYFGAEISVEPFEGGLR-IALEGRRTLQGQPVAVPGDPSSAAF 240 Query: 251 PLVAALLVEGSDVTIRNVLMNPTRTGLILTLQEMGADIEVLNARLAGGEDVADLRVKASK 310 + AAL+ SD+ ++NVL+NPTRTG TL EMGADI N R GE VAD+R + S+ Sbjct: 241 LVAAALITPASDILVKNVLVNPTRTGFYETLAEMGADISFENEREVSGEPVADIRARTSE 300 Query: 311 LKGVVVPPERAPSMIDEYPVLAIAAAFAEGETVMDGLDELRVKESDRLAAVARGLEANGV 370 L+GV VP RAPSMIDEYP+LA A AEGET+M+GL ELRVKESDRLAA+ GL A G Sbjct: 301 LRGVTVPAARAPSMIDEYPMLAALATLAEGETLMEGLAELRVKESDRLAAMVDGLVACGA 360 Query: 371 DCTEGEMSLTVRGRPDGKGLGGGTVATHLDHRIAMSFLVMGLASEKPVTVDDSTMIATSF 430 +LTV G P K GG T+ TH+DHRIAMSFLV+GLA+E+PVTVDD++MIATSF Sbjct: 361 IAHARGDTLTVLGLP--KVRGGATIKTHMDHRIAMSFLVLGLATEEPVTVDDASMIATSF 418 Query: 431 PEFMDMMPGLGAKIE 445 PEF +M +GA ++ Sbjct: 419 PEFRTLMQQVGATLD 433 Lambda K H 0.316 0.135 0.381 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 650 Number of extensions: 27 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 450 Length of database: 448 Length adjustment: 33 Effective length of query: 417 Effective length of database: 415 Effective search space: 173055 Effective search space used: 173055 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 51 (24.3 bits)
Align candidate WP_245258033.1 RVAN_RS04590 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.2719890.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 7.3e-128 412.8 0.1 8.2e-128 412.6 0.1 1.0 1 NCBI__GCF_000166055.1:WP_245258033.1 Domain annotation for each sequence (and alignments): >> NCBI__GCF_000166055.1:WP_245258033.1 # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 412.6 0.1 8.2e-128 8.2e-128 1 414 [. 10 430 .. 10 431 .. 0.95 Alignments for each domain: == domain 1 score: 412.6 bits; conditional E-value: 8.2e-128 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakveee.keelviegvgg..lkepe 70 g + +pg+KSishRal+l+aLaeg+t++t+lL++eD+l t +al++lGa ve++ ++ ++++g g l+ p NCBI__GCF_000166055.1:WP_245258033.1 10 GAVVVPGDKSISHRALILGALAEGRTRITGLLEAEDILCTARALEALGAGVERDaDGAWTVTGRGLggLAAPA 82 67889***********************************************666*******988778***** PP TIGR01356 71 aeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgplkg. 142 ld+gnsGt aRl++gv+a ++ +tgd sl+kRP++r++ +L+++g ie++ +++lPl++ g+ + NCBI__GCF_000166055.1:WP_245258033.1 83 GDLDFGNSGTGARLMMGVVAGHPLAARFTGDASLQKRPMGRVLAPLQSMGLAIEEEG-RNTLPLTLVGTGDLv 154 ******************************************************866.68*********7777 PP TIGR01356 143 givelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeede.rkivvkggqk 214 +i++ + S+Q+ksa+lla+ l a++++ v+e+++sr+++e++L ++++ ++ve ++ +i ++g + NCBI__GCF_000166055.1:WP_245258033.1 155 PISYRLPVPSAQVKSAVLLAG---LFASGETSVIESEKSRDHTEKMLRYFGAE-ISVEPFEGgLRIALEGRRT 223 *********************...66789999999****************99.9999877758888888888 PP TIGR01356 215 ykqkevevegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeqr........dv 278 + + v+v+gD+SsAaf++aaa+it+ ++ v+n++ n+t+++ + ++L emGad+++e++r d+ NCBI__GCF_000166055.1:WP_245258033.1 224 LQGQPVAVPGDPSSAAFLVAAALITPAsDILVKNVLVNPTRTG--FYETLAEMGADISFENERevsgepvaDI 294 55555**************************************..888***************9999999999 PP TIGR01356 279 evegasklkgvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGveveele 350 + + +s+l+gv+v ++++s+iDe+p+la+la++Aeget +++++elRvkEsdR+aa+++ L + G+ ++ + NCBI__GCF_000166055.1:WP_245258033.1 295 RAR-TSELRGVTVpAARAPSMIDEYPMLAALATLAEGETLMEGLAELRVKESDRLAAMVDGLVACGAIAHARG 366 999.789******88********************************************************** PP TIGR01356 351 dgllieGkkkelkg.avvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfevleqlga 414 d l++ G +++g a+++t+ DHRiam++ vlgla e++v+++da+++a+sfPeF +++q+ga NCBI__GCF_000166055.1:WP_245258033.1 367 DTLTVLGLP-KVRGgATIKTHMDHRIAMSFLVLGLATEEPVTVDDASMIATSFPEFRTLMQQVGA 430 ********6.66655***********************************************987 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (448 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.00u 0.01s 00:00:00.01 Elapsed: 00:00:00.00 # Mc/sec: 26.15 // [ok]
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory